Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-07

Clinical Trial Update: Clarithromycin in Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating clarithromycin for active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • clarithromycin (clarithromycin)

Snippet

Sponsor: Royal Liverpool University Hospital | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED